Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,552 | 21,181 | 25,878 | 30,215 | 33,428 |
| Receivables | 177 | 235 | 207 | 216 | 227 |
| TOTAL | $18,912 | $22,711 | $26,782 | $31,638 | $34,696 |
| Non-Current Assets | |||||
| PPE Net | 192 | 222 | 250 | 277 | 200 |
| Intangibles | 123 | 140 | 156 | 173 | 188 |
| TOTAL | $315 | $363 | $406 | $450 | $388 |
| Total Assets | $19,227 | $23,074 | $27,188 | $32,087 | $35,085 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,892 | 6,563 | 5,957 | 5,360 | 5,332 |
| Other current liabilities | 991 | 1,517 | 176 | 604 | 895 |
| TOTAL | $7,898 | $8,092 | $6,145 | $5,985 | $6,262 |
| Non-Current Liabilities | |||||
| TOTAL | $104 | $112 | $117 | $113 | $N/A |
| Total Liabilities | $8,002 | $8,204 | $6,263 | $6,098 | $6,262 |
| Shareholders' Equity | |||||
| Common Shares | 111,322 | 112,004 | 110,023 | 110,136 | 109,840 |
| Retained earnings | -115,704 | -112,497 | -105,621 | -100,571 | -95,957 |
| Other shareholders' equity | 0 | 2,608 | 2,606 | 2,622 | 2,617 |
| TOTAL | $11,224 | $14,870 | $20,925 | $25,989 | $28,822 |
| Total Liabilities And Equity | $19,227 | $23,074 | $27,188 | $32,087 | $35,085 |